News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,099 Results
Type
Article (42699)
Company Profile (439)
Press Release (677960)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (208887)
Career Advice (2025)
Deals (36047)
Drug Delivery (105)
Drug Development (83692)
Employer Resources (173)
FDA (16514)
Job Trends (15132)
News (353182)
Policy (33155)
Tag
Academia (2645)
Accelerated approval (12)
Adcomms (26)
Allergies (98)
Alliances (51105)
ALS (115)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (168)
Approvals (16492)
Artificial intelligence (331)
Autoimmune disease (33)
Automation (19)
Bankruptcy (373)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (124)
Biotechnology (331)
Bladder cancer (99)
Brain cancer (36)
Breast cancer (377)
Cancer (2970)
Cardiovascular disease (227)
Career advice (1695)
Career pathing (30)
CAR-T (194)
CDC (32)
Cell therapy (527)
Cervical cancer (22)
Clinical research (68702)
Collaboration (1071)
Company closure (3)
Compensation (703)
Complete response letters (28)
COVID-19 (2686)
CRISPR (65)
C-suite (344)
Cystic fibrosis (119)
Data (3064)
Decentralized trials (2)
Denatured (31)
Depression (71)
Diabetes (351)
Diagnostics (6486)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (147)
Drug pricing (131)
Drug shortages (29)
Duchenne muscular dystrophy (137)
Earnings (88727)
Editorial (44)
Employer branding (21)
Employer resources (149)
Events (117380)
Executive appointments (874)
FDA (18204)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (977)
Gene editing (143)
Generative AI (23)
Gene therapy (407)
GLP-1 (826)
Government (4595)
Grass and pollen (4)
Guidances (182)
Healthcare (19172)
HIV (42)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (164)
Immuno-oncology (9)
Indications (40)
Infectious disease (2862)
Inflammatory bowel disease (156)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (122)
Interviews (312)
IPO (16875)
IRA (48)
Job creations (3708)
Job search strategy (1436)
Kidney cancer (13)
Labor market (53)
Layoffs (528)
Leadership (20)
Legal (8006)
Liver cancer (80)
Longevity (11)
Lung cancer (416)
Lymphoma (212)
Machine learning (11)
Management (58)
Manufacturing (402)
MASH (95)
Medical device (13616)
Medtech (13621)
Mergers & acquisitions (19894)
Metabolic disorders (888)
Multiple sclerosis (99)
NASH (19)
Neurodegenerative disease (132)
Neuropsychiatric disorders (39)
Neuroscience (2224)
NextGen: Class of 2025 (6759)
Non-profit (4558)
Now hiring (48)
Obesity (452)
Opinion (237)
Ovarian cancer (103)
Pain (113)
Pancreatic cancer (123)
Parkinson's disease (193)
Partnered (22)
Patents (306)
Patient recruitment (171)
Peanut (51)
People (59101)
Pharmaceutical (86)
Pharmacy benefit managers (22)
Phase I (21595)
Phase II (30319)
Phase III (22391)
Pipeline (1672)
Policy (214)
Postmarket research (2601)
Preclinical (9276)
Press Release (67)
Prostate cancer (146)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (492)
Real estate (6025)
Recruiting (67)
Regulatory (23124)
Reports (50)
Research institute (2422)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (169)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3776)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (58)
The Weekly (58)
Vaccines (802)
Venture capital (56)
Weight loss (278)
Women's health (49)
Worklife (17)
Date
Today (90)
Last 7 days (379)
Last 30 days (1864)
Last 365 days (32002)
2025 (17381)
2024 (36302)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (738)
Alabama (67)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (39661)
Australia (6581)
California (7615)
Canada (2383)
China (696)
Colorado (328)
Connecticut (334)
Delaware (195)
Europe (86736)
Florida (1129)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (663)
India (27)
Indiana (365)
Iowa (19)
Japan (232)
Kansas (112)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1049)
Massachusetts (5765)
Michigan (248)
Minnesota (461)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (70)
New Jersey (2127)
New Mexico (30)
New York (2124)
North Carolina (1153)
North Dakota (9)
Northern California (3324)
Ohio (240)
Oklahoma (16)
Oregon (38)
Pennsylvania (1635)
Puerto Rico (17)
Rhode Island (37)
South America (1112)
South Carolina (34)
South Dakota (1)
Southern California (2842)
Tennessee (126)
Texas (1150)
United States (28350)
Utah (223)
Virginia (193)
Washington D.C. (74)
Washington State (660)
West Virginia (4)
Wisconsin (70)
721,099 Results for "cerenis therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Press Releases
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
July 16, 2025
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners
June 16, 2025
·
6 min read
Press Releases
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
May 29, 2025
·
4 min read
Press Releases
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 1, 2025
July 2, 2025
·
2 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. Selected to Present at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida
May 21, 2025
·
4 min read
Press Releases
1Elevan Biopharmaceuticals, Inc. Announces the Development of Its Next-Generation Peptide Therapeutics Headquarters in Fishers, Indiana
June 18, 2025
·
3 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
June 12, 2025
·
5 min read
Press Releases
Precisio Biotix Therapeutics, Inc. (Precisio) Announces Dosing of a First Patient with ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection
July 3, 2025
·
3 min read
1 of 72,110
Next
